Aakash Desai, Associate Director, Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared a post by Oncology News Central, on X, adding:
“Great conversation on intensification for EGFR– mutated NSCLC with Jorge Nieva, (USC Norris Comprehensive Cancer Center). Was an exciting discussion about new options and how to use them!
Quoting Oncology News Central‘s post:
“Treatment intensification for EGFR-mutated NSCLC isn’t just a clinical call – it’s a values-based one. Jorge Nieva, (USC Norris Comprehensive Cancer Center): Focus on patient goals, not just biomarkers.”
Other articles about NSCLC on OncoDaily.